RxSight, Inc. (RXST): Company Cash Volume

Official company branding of RxSight Corp (RXST)

The RxSight, Inc. (RXST) cash volume chart demonstrates liquidity supported by the implementation of innovative light-adjustable lenses through surgeon training. Active growth is driven by the demand for laser vision adjustment systems. Meanwhile, the value of 0.25 is a current metric assigned to the company, whose position is protected by strict FDA certification and exclusive patents that create an insurmountable barrier for new entrants.

Company Cash Funds: RxSight Ophthalmic (RXST) for 07/04/2022 - 11/21/2026

Summary analytical data breakdowns for RxSight Inc (RXST)

- stock quotes and analyst forecast:
- stock exchange capitalization data:
Initial company analysis:RxSight Ophthalmic RXST
Brand item of RxSight

Complex FDA certification and patent protection for LAL lenses require RxSight, Inc. (RXST) to maintain significant reserves to sustain its technological edge. This metric measures the actual volume of liquid assets on balance, determining the company's financial autonomy and capital density. Analyzing current cash holdings allows investors to filter out short-term volatility and identify the real liquidity trend. Comparing these resources to market value helps investors objectively assess the extent to which the asset is undervalued.

Analysis of competing companies

Company Cash Volume BSX|Company Cash Funds EW (Edwards Lifesciences Corporation)|Company Cash Funds ResMed RMD|Company Cash Volume Insulet Corp PODD|ZBH: Company Cash on Hand|Company Cash Balance COO (CooperVision)|ALGN (Align Technology, Inc.) - Company Cash on Hand|Globus Medical, Inc. - Company Cash Balance|TMDX (TransMedics Group Inc) - Company Cash Volume|Company Cash Reserve Alphatec Holdings ATEC|Company Cash Funds CryoLife (AORT)|Enovis Corporation (ENOV) - Company Cash Position|Integra LifeSciences Inc. - Company Cash on Hand|Company Cash Volume Establishment Labs ESTA|Beta Bionics, Inc. - Company Cash Volume|Company Liquid Assets IRADIMED Corp IRMD|Embecta (EMBC) - Company Cash Funds|Company Total Cash Volume TNDM (Tandem Corp)|Company Cash Funds axogeninc.com|Company Cash on Hand SI-BONE, Inc. (SIBN)|Company Cash Volume OFIX|Bioventus Corp - Company Cash and Cash Equivalents|Company Cash Funds orthopediatrics.com KIDS|TMCI: Company Cash and Cash Equivalents|SRTA: Company Cash on Hand|Carlsmed Inc - Company Total Cash Amount|CLPT: Company Cash Volume|STXS - Company Liquid Assets|STIM (neurostar.com) - Company Cash Volume|Sight Sciences, Inc (SGHT) - Company Liquid Assets|Company Cash Volume OBIO|Company Liquid Assets Anika Therapeutics Inc.|Company Cash Funds InspireMD, Inc. NSPR|Company Cash Balance ZJYL|VANI - Company Cash Funds|Xtant Medical Holdings, Inc. - Company Total Cash Amount|NeuroOne (NMTC) - Company Cash Funds|Modular Med (MODD) - Company Cash Volume|Company Cash Funds Myomo, Inc|Company Cash on Hand Envoy Medical (COCH)|Company Cash Volume VVOS|NVNO (enVVeno Corp) - Company Cash Balance|Company Cash Volume SINT (Sintx Technologies)|TNON: Company Cash and Cash Equivalents|Lifeward - Company Cash Volume|Company Cash Balance AMIX (Autonomix Medical)|IVF: Company Cash Volume|Company Cash Position Bone Biologics Corporation BBLG|Company Cash on Hand AXNX|BIOLASE, Inc. (BIOL) - Company Liquid Assets|Company Cash Volume DYNT|Company Liquid Assets Paragon 28|Company Cash Volume INVO (INVO Bioscience, Inc.)